Abstract
A 61-year-old woman was admitted to our hospital because of an unexpected rise in serum creatinine (sCr) level with proteinuria and microhematuria. She had undergone living-donor kidney transplantation 31 years before for end-stage renal disease caused by chronic glomerulonephritis (GN). On admission, her sCr was 1.27 mg/dL which was increased from 0.6 mg/dL, urinary protein/creatinine ratio was 1.39 g/gCr, and urinary red blood cell count was more than 100 per high power field. The allograft biopsy revealed crescentic glomerulonephritis with moderate to severe tubulointerstitial inflammation. Immunofluorescence staining yielded only a minimal staining for immunoglobulin A, and negative C4d in peritubular capillary. Since increased myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) titer of 45.5 U/mL was detected, we made the diagnosis of post-transplant MPO-ANCA-associated GN. She was treated with three doses of bolus methylprednisolone (500 mg) followed by oral prednisolone therapy. Her sCr was stable at 1.20 mg/dL thereafter. ANCA-associated GN should be considered in older kidney transplant patients with new-onset urinary abnormalities because typical systemic symptoms and vasculitis in other organs might be masked by maintenance immunosuppression.
References
Gomez-Puerta JA, Bosch X. Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis an update. Am J Pathol. 2009;175:1790–8.
Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int. 2007;56:87–96.
Ozaki S, Atsumi T, Hayashi T, et al. Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol. 2012;22:394–404.
Fujimoto S, Watts RA, Kobayashi S, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK. Rheumatology (Oxford). 2011;50:1916–20.
Gómez-Puerta JA, Hernández-Rodríguez J, López-Soto A, et al. Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease. Chest. 2009;136:1101–11.
Homma S, Matsushita H, Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology. 2004;9:190–6.
Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum. 1999;42:421–30.
Geetha D, Eirin A, True K, et al. Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience. Transplantation. 2011;91:1370–5.
Dhaun N, Blakeney J, Richards A, et al. Recurrent ANCA-associated vasculitis after renal transplantation. Transplantation. 2010;90:1239–40.
Nachman PH, Segelmark M, Westman K, et al. Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int. 1999;56:1544–50.
Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347:103–9.
Asif A, Toral C, Diego J, et al. De novo ANCA-associated vasculitis occurring 14 years after kidney transplantation. Am J Kidney Dis. 2000;35:E10.
Tabata H, Honda K, Moriyama T et al. Two cases of ANCA-associated vasculitis in post-transplant kidney: relapse and de novo. Clin Transplant 2009;23(Suppl 20):S49–53.
Haas M, Sis B, Racusen LC, As the Banff meeting report writing committee. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14:272–83.
Geetha D, Seo P. Renal transplantation in the ANCA-associated vasculitides. Am J Transplant. 2007;7:2657–62.
Sun Q, Cheng D, Wen J, et al. Successful renal transplantation in a patient with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis: effect of early plasma exchange and mycophenolate mofetil. Transplant Proc. 2008;40:3764–6.
Geetha D, Seo P, Specks U, et al. Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two cases. Am J Transplant. 2007;7:2821–5.
Hoffman GS, Karr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis 158 patients. Ann Intern Med. 1996;116:488–98.
Deegens JKJ, Artz MA, Hoitsma AJ, et al. Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis and anti-GBM disease. Clin Nephrol. 2003;59:1–9.
Conflict of interest
Honoraria: Kazuhiko Tsuruya (Kyowa Hakko Kirin Co., Chugai Pharmaceutical Co.), Research funding: Kazuhiko Tsuruya (Kyowa Hakko Kirin Co., Chugai Pharmaceutical Co., Fuso Pharmaceutical Industries, MSD K.K., Takeda Pharmaceutical Co.), Endowed department: Kazuhiko Tsuruya (Baxter).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Haruyama, N., Tsuchimoto, A., Masutani, K. et al. De novo myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis 31 years after living-donor kidney transplantation. CEN Case Rep 4, 14–19 (2015). https://doi.org/10.1007/s13730-014-0131-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-014-0131-4